Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan Lauw

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Bio-Protocol|May 27, 2026
Biolayer Interferometry (BLI) to Quantify RALF1-Pectin InteractionsSusan Lauw, Elke Barbez
The FEBS Journal|July 12, 2008
Biosynthesis of isoprenoids: studies on the mechanism of 2C-methyl-D-erythritol-4-phosphate synthaseSusan Lauw, Victoria Illarionova, Adelbert Bacher, et al.
The FEBS Journal|September 16, 2006
Isoprenoid biosynthesis in plants - 2C-methyl-D-erythritol-4-phosphate synthase (IspC protein) of Arabidopsis thalianaFelix Rohdich, Susan Lauw, Johannes Kaiser, et al.
Cancer Genomics & Proteomics|June 29, 2024
Photoimmunotherapy of HER2-expressing Breast Cancer CellsLukas Klemenz, Isis Wolf, Jonas Storz, et al.
Nanoscale|December 8, 2021
Designed membrane protein heterodimers and control of their affinity by binding domain and membrane linker propertiesChenyang Lan, Anja Stulz, Nicolas P F Barthes, et al.
Elife|October 3, 2024
Pectin methylesterase activity is required for RALF1 peptide signalling outputAnn-Kathrin Rößling, Kai Dünser, Chenlu Liu, et al.
Chemmedchem|March 17, 2007
Nonphosphate inhibitors of IspE protein, a kinase in the non-mevalonate pathway for isoprenoid biosynthesis and a potential target for antimalarial therapyAnna K H Hirsch, Susan Lauw, Philipp Gersbach, et al.
Anticancer Research|May 31, 2024
Photoimmunotherapy of Prostate Cancer With Antibody and Fab Fragments Targeting the Prostate Specific Membrane AntigenSarah Waibel, Nele Graf, Jonas Storz, et al.
Angewandte Chemie (International Ed. in English)|January 5, 2006
Fluorescent inhibitors for IspF, an enzyme in the non-mevalonate pathway for isoprenoid biosynthesis and a potential target for antimalarial therapyChristine M Crane, Johannes Kaiser, Nicola L Ramsden, et al.
Anticancer Research|April 27, 2024
Antibody-dye Conjugates Targeting EGFR and HER2 for the Photoimmunotherapy of Bladder CancerFabian Huber, Isis Wolf, Jonas Storz, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Bio-Protocol|May 27, 2026
Biolayer Interferometry (BLI) to Quantify RALF1-Pectin InteractionsSusan Lauw, Elke Barbez
The FEBS Journal|July 12, 2008
Biosynthesis of isoprenoids: studies on the mechanism of 2C-methyl-D-erythritol-4-phosphate synthaseSusan Lauw, Victoria Illarionova, Adelbert Bacher, et al.
The FEBS Journal|September 16, 2006
Isoprenoid biosynthesis in plants - 2C-methyl-D-erythritol-4-phosphate synthase (IspC protein) of Arabidopsis thalianaFelix Rohdich, Susan Lauw, Johannes Kaiser, et al.
Cancer Genomics & Proteomics|June 29, 2024
Photoimmunotherapy of HER2-expressing Breast Cancer CellsLukas Klemenz, Isis Wolf, Jonas Storz, et al.
Nanoscale|December 8, 2021
Designed membrane protein heterodimers and control of their affinity by binding domain and membrane linker propertiesChenyang Lan, Anja Stulz, Nicolas P F Barthes, et al.
Elife|October 3, 2024
Pectin methylesterase activity is required for RALF1 peptide signalling outputAnn-Kathrin Rößling, Kai Dünser, Chenlu Liu, et al.
Chemmedchem|March 17, 2007
Nonphosphate inhibitors of IspE protein, a kinase in the non-mevalonate pathway for isoprenoid biosynthesis and a potential target for antimalarial therapyAnna K H Hirsch, Susan Lauw, Philipp Gersbach, et al.
Anticancer Research|May 31, 2024
Photoimmunotherapy of Prostate Cancer With Antibody and Fab Fragments Targeting the Prostate Specific Membrane AntigenSarah Waibel, Nele Graf, Jonas Storz, et al.
Angewandte Chemie (International Ed. in English)|January 5, 2006
Fluorescent inhibitors for IspF, an enzyme in the non-mevalonate pathway for isoprenoid biosynthesis and a potential target for antimalarial therapyChristine M Crane, Johannes Kaiser, Nicola L Ramsden, et al.
Anticancer Research|April 27, 2024
Antibody-dye Conjugates Targeting EGFR and HER2 for the Photoimmunotherapy of Bladder CancerFabian Huber, Isis Wolf, Jonas Storz, et al.
Pageof 2